News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,194 Results
Type
Article (89678)
Company Profile (639)
Press Release (807853)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (267514)
Career Advice (4176)
Deals (40164)
Drug Delivery (246)
Drug Development (92152)
Employer Resources (212)
FDA (18737)
Job Trends (17563)
News (399635)
Policy (40038)
Tag
2025 Best Places to Work (25)
2026 Best Places to Work (39)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (13)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (10)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (76)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2152)
Antibody-drug conjugate (ADC) (779)
Approvals (19336)
Artificial intelligence (1147)
ASCO (350)
Autoimmune disease (537)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (308)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (60)
Bladder cancer (253)
Brain cancer (104)
Breast cancer (981)
Cancer (8072)
Cardiovascular disease (684)
Career advice (3638)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (237)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1280)
Cervical cancer (69)
Clinical research (81250)
Collaboration (2896)
Commercialization (76)
Company closure (10)
Compensation (1937)
Complete response letters (128)
COVID-19 (3089)
CRISPR (155)
CRO (8)
C-suite (1713)
Cystic fibrosis (183)
Data (11184)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (208)
Diabetes (855)
Diagnostics (7950)
Digital health (86)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (566)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (104815)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (141996)
Executive appointments (1385)
Eye disease (28)
FDA (23875)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2385)
Gene editing (323)
Generative AI (116)
Gene therapy (991)
GLP-1 (1416)
Government (5635)
Grass and pollen (8)
Guidances (446)
Healthcare (21523)
Hematology (236)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (432)
Immuno-oncology (166)
Indications (299)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (391)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (32)
Kidney disease (182)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (132)
Liver cancer (121)
Longevity (58)
Lung cancer (1111)
Lung diease (27)
Lymphoma (567)
Machine learning (78)
Management (72)
Manufacturing (1662)
Marketing (41)
MASH (260)
Medical affairs (5)
Medical device (15487)
Medtech (15824)
Mergers & acquisitions (23653)
Metabolic disorders (2176)
Middle East (2)
mRNA (345)
Multiple sclerosis (263)
Multispecific (6)
NASH (24)
Netherlands (41)
Neurodegenerative disease (637)
Neuropsychiatric disorders (155)
Neuroscience (4373)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (101)
Obesity (1028)
Opinion (410)
Ovarian cancer (301)
Pain (352)
Pancreatic cancer (459)
Parkinson's disease (496)
Partnered (53)
Patents (816)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (69167)
Peptides (45)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25056)
Phase 2 (35292)
Phase 3 (26605)
Pipeline (14699)
Policy (435)
Postmarket research (3561)
Preclinical (11211)
Press Release (74)
Prostate cancer (414)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (449)
Rare diseases (1617)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31913)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (410)
Series B (285)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4405)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1449)
Venture capital (186)
Weight loss (683)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (248)
Last 7 days (992)
Last 30 days (4065)
Last 365 days (34040)
2026 (30823)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (493)
Arkansas (17)
Asia (53212)
Australia (9371)
California (17382)
Canada (4783)
China (2070)
Colorado (772)
Connecticut (776)
Delaware (549)
Europe (122873)
Florida (2633)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1502)
India (156)
Indiana (786)
Iowa (37)
Japan (783)
Kansas (159)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2049)
Massachusetts (12579)
Michigan (477)
Minnesota (954)
Mississippi (8)
Missouri (190)
Montana (38)
Nebraska (31)
Nevada (206)
New Hampshire (94)
New Jersey (4602)
New Mexico (38)
New York (4529)
North Carolina (2250)
North Dakota (14)
Northern California (8879)
Ohio (543)
Oklahoma (32)
Oregon (55)
Pennsylvania (3326)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6928)
Tennessee (287)
Texas (2894)
United States (61607)
Utah (528)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1387)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,194 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annovis Receives Second Positive DSMB Recommendation for its Phase 3 DUET-AD Study
November 17, 2026
·
2 min read
Press Releases
Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal Cancer
November 17, 2026
·
10 min read
Press Releases
BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026
November 17, 2026
·
6 min read
Licensing
Lilly pens another deal, inking up to $5.9B oncology pact with Stipple
A licensing pact with Stipple Bio was one of two announced by Eli Lilly on Monday, after the up to $1.5 billion buyout of blood cancer-focused Calytrix Bio.
November 17, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
November 17, 2026
·
13 min read
Press Releases
Karyopharm Announces FDA Acceptance of Supplemental New Drug Application for XPOVIO® (selinexor) Plus Ruxolitinib for the Treatment of Patients with Myelofibrosis
November 17, 2026
·
13 min read
Press Releases
Newton’s Neurolens® N3 Receives CE Mark Under EU MDR
November 17, 2026
·
4 min read
Press Releases
Acoramidis Was Associated with Lower Risk of Worsening Heart Failure Versus Tafamidis in Real-World Study and Reduced Heart Failure Events Within One Month in ATTRibute-CM
November 17, 2026
·
20 min read
Press Releases
Nine-month interim report (Q3) 2026 (unaudited)
November 17, 2026
·
3 min read
Press Releases
Medicenna Therapeutics Reports Second Quarter Fiscal 2027 Financial Results and Provides Corporate Update
November 17, 2026
·
11 min read
1 of 89,820
Next